Which is more serious: pelvic adhesions or intrauterine adhesions?

       It is not possible to definitively state whether pelvic adhesions or intrauterine adhesions (Asherman’s syndrome) are more severe—both conditions are serious and require prompt evaluation and treatment at a reputable hospital upon diagnosis to prevent adverse effects on health. Specific details are as follows:

       Intrauterine adhesions and pelvic adhesions are two distinct gynecological disorders. The primary symptoms of intrauterine adhesions include oligomenorrhea (scanty menstrual flow), dysmenorrhea (painful menstruation), and infertility. Pelvic adhesions typically manifest as lower abdominal pain, a sensation of heaviness or pressure in the lower abdomen, tenderness or rebound tenderness in the adnexal region, and may be accompanied by abnormal vaginal discharge—such as increased volume, yellow discoloration, or foul odor. Severe cases of either condition often necessitate surgical intervention: hysteroscopic adhesiolysis for intrauterine adhesions and laparoscopic adhesiolysis for pelvic adhesions—commonly performed as a combined hysteroscopic-laparoscopic procedure. Without timely surgical management, both conditions pose significant risks to overall health. Moreover, postoperative anti-inflammatory therapy is essential to minimize the risk of recurrence.

       In summary, both intrauterine and pelvic adhesions are serious gynecological conditions. Should any related symptoms arise, patients must seek timely evaluation and treatment at a qualified medical institution. During treatment, strict adherence to nursing care guidelines is crucial—including complete abstinence from sexual intercourse to prevent cross-infection.